drugset / Trial / NCT01295047

Comparison of Medical Therapies in Marfan Syndrome.

NCT01295047

Phase 4 Completed 18 enrolled Cardiff University
RandomizedCrossoverQuadruple-blindTreatment

Summary

The investigators are looking at the different impacts of atenolol, verapamil and perindopril on large artery and lv function in marfan syndrome. It is a double-blind, randomised cross-over trial.

Timeline

Start
2006-07
Primary completion
2007-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atenolol Other / unclassified 75 mg
Comparator Perindopril Small molecule 4 mg
Comparator Verapamil Other / unclassified 240 mg

Indications